MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition

New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a range of new substances that effect the central nervous system. VANCOUVER, British Columbia, April 13, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has completed the development of new technology Intox Collect™ which has enabled the Company to rapidly scale its collection and analysis of data samples (including voice and facial recognition data) from a wide range of substances when consumed.